India
Earlier, the duty exemption and concessional rates for COVID and related medicines were applicable till September 30.
Updated : Sep 17, 2021, 10:57 PM IST | Edited by : Riddhima Kanetkar
Union Finance Minister Nirmala Sitharaman on Friday said that the applicability of concessional GST rates on COVID-19 and cancer-related medicines has been extended till December 31, 2021.
The Council also reduced GST from 12 to 5 percent on cancer-related drugs and seven other medicines. Finance Minister Sitharaman said that the council has granted tax exemption on drugs to treat muscular atrophy imported for personal use only.
Earlier, the duty exemption and concessional rates for COVID and related medicines were applicable till September 30.
In June, India had cut taxes on medical equipment such as oxygen concentrators and drugs used to treat COVID-19 such as to 5% from 12-18%.
The cut had been due to expire this month, but the deadline was extended by the Goods and Services Tax (GST) council, comprised of state and federal finance ministers, which met physically after a gap of nearly two years.
Drugs covered by the extension of lower tax rates include Zolgensma, Viltepso, Remdesivir, Favipiravir, and Itolizumab.
Coronavirus cases in the world's second-most populous country have fallen to below 35,000 a day after hitting a peak of 400,000 a day in May, data from the health ministry showed.
The GST council also made changes to rules to require food delivery services to collect an existing 5% tax on behalf of restaurants from January, describing this as a measure to reduce tax evasion.
"The impact on the end consumer is expected to be neutral where the restaurant is a registered one," said Mahesh Jaising, Partner, Deloitte India, adding there could be a 5% tax going forward on unregistered restaurants using these platforms.